{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:33:31Z","timestamp":1790912011906,"version":"4.1.0"},"reference-count":28,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Lung Cellular and Molecular Physiology"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:p>The anorectic agent dexfenfluramine (dex) causes the development of primary pulmonary hypertension in susceptible patients by an unknown mechanism. We compared the effects of dex with those of its major metabolite, nordexfenfluamine (nordex), in the isolated perfused rat lung and in isolated rings of resistance pulmonary arteries. Nordex caused a dose-dependent and more intense vasoconstriction, which can be inhibited by the nonspecific 5-hydroxytryptamine type 2 (5-HT<jats:sub>2<\/jats:sub>) blocker ketanserin. Similarly a rise in cytosolic calcium concentration ([Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>) in dispersed pulmonary artery smooth muscle cells (PASMCs) induced by nordex could be prevented by ketanserin. Unlike prior observations with dex, nordex did not inhibit K<jats:sup>+<\/jats:sup>current or cause depolarization in PASMCs. Removal of Ca<jats:sup>2+<\/jats:sup>from the tissue bath or addition of nifedipine (1 \u03bcM) reduced ring contraction to nordex by 60 \u00b1 9 and 63 \u00b1 4%, respectively. The addition of 2-aminoethoxydiphenyl borate (2-APB), a blocker of store-operated channels and the inositol 1,4,5-trisphosphate receptor, caused a dose-dependent decrease in the ring contraction elicited by nordex. The combination of 2-APB (10 \u03bcM) and nifedipine (1 \u03bcM) completely ablated the nordex contraction. Likewise the release of Ca<jats:sup>2+<\/jats:sup>from the sarcoplasmic reticulum by cyclopiazonic acid markedly reduced the nordex contraction while leaving the KCl contraction unchanged. We conclude that nordex may be responsible for much of the vasoconstriction stimulated by dex, through the activation of 5-HT<jats:sub>2<\/jats:sub>receptors and that the [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>increase in rat PASMCs caused by dex\/nordex is due to both influx of extracellular Ca<jats:sup>2+<\/jats:sup>and release of Ca<jats:sup>2+<\/jats:sup>from the sarcoplasmic reticulum.<\/jats:p>","DOI":"10.1152\/ajplung.00247.2003","type":"journal-article","created":{"date-parts":[[2004,2,4]],"date-time":"2004-02-04T23:21:18Z","timestamp":1075936878000},"page":"L531-L538","source":"Crossref","is-referenced-by-count":21,"title":["Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine"],"prefix":"10.1152","volume":"286","author":[{"given":"Zhigang","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxiao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kenneth","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"REF1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350901"},{"key":"REF2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.91.2.755"},{"key":"REF3","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0037rev"},{"key":"REF4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb33375.x"},{"key":"REF5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"REF6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.0609e.x"},{"key":"REF7","unstructured":"Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun JH, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, and Robertson DW.Possible role of valvular serotonin 5-HT2Breceptors in the cardiopathy associated with fenfluramine.Mol Pharmacol57: 75-81, 2000."},{"key":"REF8","doi-asserted-by":"publisher","DOI":"10.4065\/78.6.730"},{"key":"REF9","doi-asserted-by":"crossref","unstructured":"Grynkiewicz G, Poenie M, and Tsien RY.A new generation of Ca2+indicators with greatly improved fluorescence properties.J Biol Chem260: 3440-3450, 1985.","DOI":"10.1016\/S0021-9258(19)83641-4"},{"key":"REF10","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199810000-00007"},{"key":"REF11","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01488-0"},{"key":"REF12","doi-asserted-by":"publisher","DOI":"10.4065\/78.6.684"},{"key":"REF13","doi-asserted-by":"publisher","DOI":"10.1038\/nm764"},{"key":"REF14","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.039883"},{"key":"REF15","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00104.2002"},{"key":"REF16","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.22.6615"},{"key":"REF17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.279.4.H1540"},{"key":"REF18","doi-asserted-by":"publisher","DOI":"10.4065\/77.12.1280"},{"key":"REF19","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1999.277.3.L662"},{"key":"REF20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.76.1.135"},{"key":"REF21","doi-asserted-by":"crossref","unstructured":"Rich S, Kaufmann E, and Levy PS.The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.N Engl J Med372: 76-81, 1992.","DOI":"10.1056\/NEJM199207093270203"},{"key":"REF22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.23.2836"},{"key":"REF23","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.126733"},{"key":"REF24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.5.1496"},{"key":"REF25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.51.030189.001531"},{"key":"REF26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.9.2216"},{"key":"REF27","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1997.272.1.L44"},{"key":"REF28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00260.2002"}],"container-title":["American Journal of Physiology-Lung Cellular and Molecular Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajplung.00247.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T15:15:59Z","timestamp":1623683759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajplung.00247.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1152\/ajplung.00247.2003"],"URL":"https:\/\/doi.org\/10.1152\/ajplung.00247.2003","relation":{},"ISSN":["1040-0605","1522-1504"],"issn-type":[{"value":"1040-0605","type":"print"},{"value":"1522-1504","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}